Brief reportPredictors of thrombotic complications after placement of the flexible coil stent☆
References (17)
- et al.
Coronary stenting for treatment of acute or threatened closure following dissection after coronary balloon angioplasty
Am Heart J
(1993) - et al.
Emergent stenting for refractory acute coronary artery occlusion during coronary angioplasty
Am J Cardiol
(1990) - et al.
Long-term clinical and angiographic follow-up of patients treated with the self-expanding coronary stent for acute occlusion during balloon angioplasty of the right coronary artery
J Am Coll Cardiol
(1992) - et al.
A new digital electronic caliper for measurement of coronary arterial stenosis: comparison with visual estimates and computer-assisted measurements
Am J Cardiol
(1984) - et al.
Assessment of stenoses in coronary angioplasty. Inter- and intraobserver variability
Int J Cardiol
(1983) - et al.
Intravascular stenting for stenosis of aortocoronary venous bypass grafts
J Am Coll Cardiol
(1989) - et al.
Angiographic and clinical outcome of intracoronary stenting: immediate and long-term results of a large single-center experience
J Am Coll Cardiol
(1992) - et al.
Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty
Circulation
(1992)
Cited by (85)
Long-term serial changes in platelet activation indices following sirolimus elution and bare metal stent implantation in patients with stable coronary artery disease
2017, Hellenic Journal of CardiologyCitation Excerpt :Consequently, the onset, development, and formation of the thrombus within the stent, which can also cause restenosis, are a complication in which various factors are involved, influencing platelet adhesion, endothelial function, coagulation, and fibrinolysis. Various conditions, such as incorrect stent deployment or a poor choice of size, a small stent, small vessel, bifurcation of the vessel, implantation of multiple stents, eccentric lesions, acute coronary syndrome, low ejection fraction, or subtherapeutic antiplatelet medication,9–12 are considered to be risk factors for thrombosis. However, there are some patients who show none of the above factors.
Percutaneous coronary intervention in myocardial infarction. Current concepts
2005, Revista Espanola de CardiologiaInterventional cardiology. Where are we and where are we going from here?
2005, Revista Espanola de CardiologiaClinical impact of stent construction and design in percutaneous coronary intervention
2004, American Heart JournalCitation Excerpt :Although it is highly flexible and provides greater side-branch access, the coil or coil-related stent design, such as the Gianturco-Roubin Flex/GR-II (Cook), Wiktor stent (Medtronic, Minneapolis, Minn), and GFX (Applied Vascular Engineering, Santa Rosa, Calif), nonetheless suffers from a high degree of elastic recoil and tissue prolapse and has weak radial strength. These downside features are probably the reasons for its higher early complication rate, lower acute luminal gain, and higher late loss compared with the tubular and corrugated stents,15,16 as have been demonstrated in 3 recent randomized studies.17–19 In the trial by Lansky et al,17 the GR-II stent was found to be associated with a significantly higher subacute stent thrombosis rate (3.9% vs 0.3%, P < .001), a higher restenosis rate (47.3% vs 20.6%, P < .001), and a lower 12-month event-free survival (71.7% vs 83.9%, P < .001) compared with the Palmaz-Schatz stent.
Comparison of immediate and one-year outcome after coronary angioplasty of narrowing <3 mm with those ≥3 mm (The National Heart, Lung, and Blood Institute Dynamic Registry)
2001, American Journal of CardiologyCitation Excerpt :There are limited data on the role of stent placement in the treatment of small coronary arteries (Table 7). 14–21 Earlier reports suggest a higher incidence of subacute thrombosis with the use of smaller sized stents and/or treatment of smaller coronary arteries with stents.22–24 Although this increased risk of thrombosis was not observed in other studies,15–21 a worse clinical outcome at follow-up was reported for patients with small vessels.14,17,18
Coronary stenting in small vessels: Short-term and long-term clinical outcome
2000, Revista Espanola de Cardiologia
- ☆
This work was supported in part by funding from Cook, Inc., Bloomington, Indiana. Dr. Roubin's address is: 310 Lyons-Harrison Research Building, 1919 Seventh Avenue South, Birmingham, Alabama 35294-0007.